- Home
- ALNY vs WIT Comparison
ALNY vs WIT Comparison
Compare ALNY & WIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- WIT
- Stock Information
- Founded
- ALNY 2002
- WIT 1945
- Country
- ALNY United States
- WIT India
- Employees
- ALNY N/A
- WIT N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- WIT EDP Services
- Sector
- ALNY Health Care
- WIT Technology
- Exchange
- ALNY Nasdaq
- WIT Nasdaq
- Market Cap
- ALNY 35.0B
- WIT 29.9B
- IPO Year
- ALNY 2004
- WIT N/A
- Fundamental
- Price
- ALNY $251.15
- WIT $2.82
- Analyst Decision
- ALNY Strong Buy
- WIT Hold
- Analyst Count
- ALNY 25
- WIT 1
- Target Price
- ALNY $324.54
- WIT N/A
- AVG Volume (30 Days)
- ALNY 972.8K
- WIT 7.0M
- Earning Date
- ALNY 05-01-2025
- WIT 04-16-2025
- Dividend Yield
- ALNY N/A
- WIT 1.10%
- EPS Growth
- ALNY N/A
- WIT 20.27
- EPS
- ALNY N/A
- WIT 0.15
- Revenue
- ALNY $2,348,099,000.00
- WIT $10,426,195,411.00
- Revenue This Year
- ALNY $31.88
- WIT $3.22
- Revenue Next Year
- ALNY $25.06
- WIT $5.35
- P/E Ratio
- ALNY N/A
- WIT $19.26
- Revenue Growth
- ALNY 17.21
- WIT N/A
- 52 Week Low
- ALNY $144.73
- WIT $2.55
- 52 Week High
- ALNY $304.39
- WIT $3.79
- Technical
- Relative Strength Index (RSI)
- ALNY 48.55
- WIT 41.90
- Support Level
- ALNY $245.96
- WIT $2.79
- Resistance Level
- ALNY $277.85
- WIT $2.88
- Average True Range (ATR)
- ALNY 10.60
- WIT 0.05
- MACD
- ALNY 1.41
- WIT 0.01
- Stochastic Oscillator
- ALNY 42.07
- WIT 50.00
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About WIT Wipro Limited
Wipro is a leading global IT services provider, with over 234,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive a significant portion of its revenue from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.